201 related articles for article (PubMed ID: 9473601)
1. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
Wolf A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Jan; 779(1-2):84-95. PubMed ID: 9473601
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.
Sinclair-Worley L; Uphouse L
Behav Brain Res; 2004 Jun; 152(1):129-35. PubMed ID: 15135976
[TBL] [Abstract][Full Text] [Related]
3. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2C receptor involvement in female rat lordosis behavior.
Wolf A; Caldarola-Pastuszka M; DeLashaw M; Uphouse L
Brain Res; 1999 Apr; 825(1-2):146-51. PubMed ID: 10216181
[TBL] [Abstract][Full Text] [Related]
5. Serotonin receptor involvement in effects of restraint on female rat lordosis behavior.
Uphouse L; Hiegel C; Perez E; Guptarak J
Pharmacol Biochem Behav; 2007 Apr; 86(4):631-6. PubMed ID: 17368527
[TBL] [Abstract][Full Text] [Related]
6. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
7. Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior.
Maswood N; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Aug; 802(1-2):98-103. PubMed ID: 9748522
[TBL] [Abstract][Full Text] [Related]
8. Protective actions of the 5-HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior.
Maswood S; Andrade M; Caldarola-Pastuszka M; Uphouse L
Neuropharmacology; 1996 Apr; 35(4):497-501. PubMed ID: 8793913
[TBL] [Abstract][Full Text] [Related]
9. Effects of mianserin and ketanserin on lordosis behavior after systemic treatment or infusion into the ventromedial nucleus of the hypothalamus.
Uphouse L; Colon L; Cox A; Caldarola-Pastuszka M; Wolf A
Brain Res; 1996 Apr; 718(1-2):46-52. PubMed ID: 8773765
[TBL] [Abstract][Full Text] [Related]
10. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
Selvamani A; Lincoln C; Uphouse L
Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
[TBL] [Abstract][Full Text] [Related]
11. Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.
Uphouse L; Hiegel C; Guptarak J; Maswood N
Horm Behav; 2009 Jan; 55(1):169-74. PubMed ID: 18952090
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
[TBL] [Abstract][Full Text] [Related]
13. 5-HT3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior.
Maswood N; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1997 Sep; 769(1):13-20. PubMed ID: 9374268
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptor antagonists and lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
[TBL] [Abstract][Full Text] [Related]
15. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
[TBL] [Abstract][Full Text] [Related]
16. WAY100635 and female rat lordosis behavior.
Uphouse L; Wolf A
Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
[TBL] [Abstract][Full Text] [Related]
19. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
Uphouse L; Maswood S; Jackson A
Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
